jj

Mergers and acquisitions are becoming ever more popular, with activity up 24% in the first two months of this year -- after already growing 23% in 2010. Here's how your portfolio can benefit from this trend.

Johnson & Johnson has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cartridges can leak, resulting in the delivery of less insulin than intended.

On Wednesday, a Minneapolis jury ordered Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals to pay an 87-year-old man $1.7 million because its antibiotic Levaquin damaged his Achilles tendons. It was the first verdict from about 2,600 similar lawsuits filed so far.

Johnson & Johnson expanded its recall of Acuvue TruEye contact lenses fivefold back in October, but only announced the news in Japan, where most of the recalled lenses were sold.

Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.

CEO William Weldon will apologize to Congress for a series of product recalls over the past year. The company is also expected to resume shipments of children's cold medication next week.

Was Johnson & Johnson aware of problems with its Children's Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this and other questions surrounding the massive recall of children's medicines earlier this year.

It's been about a month since Johnson & Johnson issued the largest-ever recall of children's medicine, but the fallout may be just beginning. Representatives from both J&J and the FDA are scheduled to testify at a May 27 congressional hearing as lawmakers remain concerned about how the recall was handled.

Johnson & Johnson shares are rebounding as the drug maker recovers from federal charges it paid kickbacks to a pharmacy company to boost sales of its drugs to nursing-home patients. Meantime, the Food and Drug Administration accused it of being too slow with its product recall during a Tylenol scare.